Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
YD Bio Limited Warrants logo

YD Bio Limited Warrants (YDESW) Stock Ticker

NASDAQ: YDESW · Healthcare · Biotechnology
$0.5733+9.22%
USD · as of 2026-09-27 · market cap $1.9M
Open YDESW in TickrDownload for iPhone

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full YDESW picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on YDESW
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About YD Bio Limited Warrants

YD Bio Limited specializes in pioneering diagnostic and therapeutic technologies. Its offerings encompass oncology screening solutions, regenerative treatments for ophthalmology, and advancements in exosome research. Established on February 6, 2024, the firm is based in Taipei, Taiwan.

YDESW stock facts

Ticker symbolYDESW
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$1.9M
CEOEthan Shen
Employees15
HeadquartersTaipei, TP, TW
IPO date2025-08-29
Websitewww.ydesgroup.com

What you can see for YDESW on Tickr

Live YDESW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the YDESW report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for YD Bio Limited Warrants?

The ticker symbol for YD Bio Limited Warrants is YDESW, listed on the NASDAQ Global Select.

What is YDESW?

YD Bio Limited specializes in pioneering diagnostic and therapeutic technologies. Its offerings encompass oncology screening solutions, regenerative treatments for ophthalmology, and advancements in exosome research. Established on February 6, 2024, the firm is based in Taipei, Taiwan.

HomeExploreMarketLists
All pages